NasdaqGS:PGENBiotechs
Precigen (PGEN) Is Up 7.4% After Surging Revenue And Wider 2025 Losses Are Reported – Has The Bull Case Changed?
Precigen, Inc. has reported full-year 2025 results, with revenue rising to US$9.68 million from US$3.93 million, while net loss widened to US$250.64 million and basic loss per share from continuing operations increased to US$1.37 from US$0.47, ahead of a recent virtual fireside chat with H.C. Wainwright.
The combination of sharply higher revenue and a very large year-on-year increase in net loss gives investors new data on how Precigen’s growth efforts are affecting its financial profile.
We...